Skip to content

Macrolane Prospective Survey

A Multi-center, Non-interventional, Prospective Study to Monitor Long Term Safety in Female Subjects After Treatment With Macrolane Volume Restoration Factor 20 and/or Macrolane Volume Restoration Factor 30 in the Breasts.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01223066
Enrollment
0
Registered
2010-10-18
Start date
2010-09-30
Completion date
2010-10-31
Last updated
2022-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Females Recently Treated With Macrolane VRF in the Breasts

Keywords

Macrolane

Brief summary

The study objective is to evaluate the long term safety when Macrolane Volume Restoration Factor is used in female breasts in clinical practice.

Interventions

None listed

Sponsors

Pharma Consulting Group AB
CollaboratorINDUSTRY
Galderma R&D
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Females recently treated with Macrolane Volume Restoration Factor in the breasts. * Signed informed consent

Exclusion criteria

* There are no

Design outcomes

Primary

MeasureTime frame
Adverse eventsup to 5 years

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026